✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Themis Medicare Ltd.

THEMISMED

Market Cap
₹1,050 Cr.
P/E
917.78

Themis Medicare Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
1,050 Cr
PE
PE
917
Prom Holding
Prom Holding
67.11 %
ROE (%)
ROE (%)
7.41
ROCE (%)
ROCE (%)
10.14
Div Yield (%)
Div Yield (%)
0.44
Sales
Sales
342 Cr
OPM (%)
OPM (%)
0.12 %
Debt to Equity
Debt to Equity
0.21
Institutions
Institutions
0.12 %
Individual < 2 lac
Individual < 2 lac
17.33 %
No. of Shareholders
No. of Shareholders
21,818
View more
Edit Ratio's

About

Themis Medicare Ltd. is a research-based pharmaceutical company specializing in manufacture of… Read more
Low
65
52W Range
High
148
  • Themis Medicare
  • Bajaj Healthcare
  • Kopran
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Verticals

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Themis Medicare Ltd. Business

    Themis Medicare Ltd. is a research-based pharmaceutical company focusing on Pain Management, Critical Care, and Anti-Infectives. It develops differentiated products for patient benefit.

    Themis Medicare major competitors are Bajaj Healthcare, Kopran, Shree Ganesh Remed., Haleos Labs, NGL Fine-Chem, Everest Organics, Nectar Lifesciences.
    Market Cap of Themis Medicare is ₹1,050 Crs.
    While the median market cap of its peers are ₹911 Crs.

    Themis Medicare seems to be less financially stable compared to its competitors.
    Altman Z score of Themis Medicare is 4.82 and is ranked 4 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Sep Sep Dec
    Investor Presentation Feb May May Aug Nov Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec
    Conference Call Mar Sep Sep Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Themis Medicare Ltd.
    Interview With Dr Sachin Patel, CEO, Themis Medicare and Gujarat Themis Biosyn - Sensei Kujaku
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material